Results of the Dana-Farber Cancer Institute ALL Consortium Protocol 95-01 for children with acute lymphoblastic leukemia

類似資料

• Prospective analysis of TEL/AML1-positive patients treated on Dana-Farber Cancer Institute Consortium Protocol 95-01
  著者:: Loh, Mignon L., 等
  出版事項: (2006)
• Long-term results of Dana-Farber Cancer Institute ALL Consortium protocols for children with newly diagnosed acute lymphoblastic leukemia (1985–2000)
  著者:: Silverman, Lewis B., 等
  出版事項: (2009)
• The Low Incidence of Secondary Acute Myelogenous Leukemia in Children and Adolescents Treated with Dexrazoxane for Acute Lymphoblastic Leukemia: A Report from the Dana-Farber Cancer Institute ALL Consortium
  著者:: Vrooman, Lynda M., 等
  出版事項: (2011)
• Neuropsychological Outcomes of Standard Risk and High Risk Patients Treated for Acute Lymphoblastic Leukemia on Dana-Farber ALL Consortium Protocol 95-01 at 5 Years Post Diagnosis
  著者:: Waber, Deborah P., 等
  出版事項: (2011)
• Postinduction Dexamethasone and Individualized Dosing of Escherichia Coli L-Asparaginase Each Improve Outcome of Children and Adolescents With Newly Diagnosed Acute Lymphoblastic Leukemia: Results From a Randomized Study—Dana-Farber Cancer Institute ALL Consortium Protocol 00-01
  著者:: Vrooman, Lynda M., 等
  出版事項: (2013)